register

News & Trends - Biotechnology

AusBiotech and J&J awards to celebrate greatest sector contribution to pandemic

Health Industry Hub | September 14, 2020 |

Biotech News: Nominations for the 2020 AusBiotech and Johnson & Johnson Innovation Industry Excellence Awards are open, and will recognise and celebrate life science leaders who are championing the sector and the Australian community through the worst pandemic and greatest collaboration seen in the sector.

These prestigious Awards recognise the leading lights of Australia’s world-class biotechnology, medical technology and healthcare sectors and will celebrate those who have played a critical role guiding and inspiring us locally, and shining a light on Australia globally as a leader in the response to COVID-19.

Behind these critical and timely responses are people and companies that inspire their workforce, their State, and their nation. The responses witnessed has been a truly remarkable illumination of the importance of our sector to the health, well-being and economic security of all Australians within a very difficult year.

Join 22,000+
industry professionals
in accessing the latest 
industry news, scientific insights & engaging professional development 
content from
Health Industry HubTM, 
the ONLY one-stop-hub
connecting Australia’s 
Pharma, MedTech & Biotech
industry professionals. Register now.

The AusBiotech and Johnson & Johnson Innovation Industry Excellence Awards will recognise the unsung heroes in white and blue coats who are making meaningful contributions to, or whose achievements or response has significantly impacted patient improvements, Australian public health, or the Australian biotechnology industry.

Nominations for the awards are open until Wednesday 30 September 2020 in four new categories:

  1. COVID-19 Life Science Sector Innovation Award – companies, universities, research institutes, industry associations and government organisations working to accelerate novel technologies and treatments for the management of COVID-19;
  2. COVID-19 Life Science Sector Collaboration Award – companies, universities, research institutes, industry associations and government organisations collaborating to deliver a product or service for the management of COVID-19;
  3. COVID-19 Communication Leaders Award – Key opinion leaders who have been called upon to communicate complex scientific information to the Australian public including about the importance of public health measures.
  4. Industry’s Choice Award – AusBiotech members can vote for their choice of shortlisted nominees across these three categories which they believe have had the greatest impact promoting Australia’s biotech sector internationally.

Finalists and their stories will be featured in the lead up to AusBiotech + Invest 2020 and awardees will be announced on Thursday 29 October 2020 during AusBiotech + Invest 2020.


News & Trends - MedTech & Diagnostics

APAC medtech company scores TGA approval in heart disease

APAC medtech company scores TGA approval in heart disease

Health Industry Hub | October 4, 2024 |

MedTech & Diagnostics News: An Asia Pacific medtech company has announced that its flagship drug-eluting stent (DES) has received regulatory […]

More


News & Trends - MedTech & Diagnostics

New state-based pilot to back home-grown medtech innovation

New state-based pilot to back home-grown medtech innovation

Health Industry Hub | October 4, 2024 |

MedTech & Diagnostics: In a bid to enhance opportunities for local medtech manufacturers to sell to health services, a connected […]

More


News & Trends - Pharmaceuticals

Ferring unveils first real-world evidence for faecal calprotectin approach in ulcerative colitis

Ferring unveils first real-world evidence for faecal calprotectin approach in ulcerative colitis

Health Industry Hub | October 4, 2024 |

Pharma News: Ferring Pharmaceuticals has announced results from a new study, which provides the first real-world evidence supporting the efficacy […]

More


News & Trends - Pharmaceuticals

Bayer partners with RACGP, calls for MBS reforms to boost access to long-acting contraceptives

Bayer partners with RACGP, calls for MBS reforms to boost access to long-acting contraceptives

Health Industry Hub | October 4, 2024 |

Pharma News: Australian women are calling for more accurate information about their contraceptive options, with 70% feeling inadequately educated about […]

More


This content is copyright protected. Please subscribe to gain access.